Editorial review
Educational content is reviewed for source quality, clinical boundaries, and readability. It is not medical advice; confirm care decisions with a licensed clinician.
Accessing ketamine therapy internationally depends almost entirely on where you live. Ketamine is a dissociative anesthetic first used in surgical settings that, at lower doses, has become a treatment option for depression, anxiety, PTSD, and chronic pain when other treatments haven't worked. In the United States, hundreds of private clinics and telehealth providers offer ketamine treatment, but outside the US the picture changes country by country. Legal status, medical culture, regulatory approval pathways, and insurance systems all shape what's actually available to patients.
This guide walks through ketamine therapy access across North America, Europe, Australia and New Zealand, Latin America, and Asia, along with practical steps for finding a qualified provider wherever you live or travel. For background on depression and its treatment options generally, see the National Institute of Mental Health's depression overview.
Quick Answer
Ketamine therapy access outside the United States varies widely by country. Esketamine (Spravato) has regulatory approval in the UK, EU, Australia, Japan, and Canada, but public health system coverage is limited almost everywhere, so most patients pay out of pocket at private clinics. Generic IV ketamine for depression is available off-label in Canada, the UK, Germany, Australia, Mexico, Brazil, and India, though clinic density and oversight vary considerably. Expats relying on a US telehealth ketamine prescription generally need to be physically present in the state where their provider is licensed.
The United States has the most developed ketamine therapy infrastructure in the world. Hundreds of private clinics offer IV ketamine infusions for depression, anxiety, PTSD, and chronic pain, and esketamine (Spravato), the FDA-approved nasal spray for treatment-resistant depression, is available through certified healthcare settings under a Risk Evaluation and Mitigation Strategy (REMS), a program the FDA requires for medications with serious safety risks to ensure administration happens under medical supervision. Telehealth providers have expanded access to at-home sublingual ketamine in most states. Generic ketamine is used off-label, meaning physicians can legally prescribe it, but it hasn't gone through FDA approval specifically for depression. See our comparison of ketamine versus esketamine for how the two differ in cost, delivery, and insurance coverage. Insurance coverage for generic ketamine remains limited, while Spravato has broader coverage through major plans.
Canada's ketamine therapy landscape is growing but less developed. Ketamine is legally available and can be prescribed off-label by physicians for depression, with clinics in Toronto, Vancouver, Montreal, and Calgary offering IV infusions. Esketamine has Health Canada approval and is available through specialized clinics, though access varies by province. Provincial health insurance generally does not cover ketamine for depression, so most patients pay out of pocket, at prices broadly comparable to US rates. Canadian physicians also navigate prescribing regulations that differ from province to province.
The UK has a small but growing number of private ketamine clinics, mostly in London and other major cities. Ketamine is a Class B controlled substance under UK law, but licensed physicians can prescribe it for medical use, and private clinics offer both IV infusions and nasal spray treatment for treatment-resistant depression. The National Health Service (NHS) does not routinely offer ketamine therapy for depression. Esketamine has been evaluated by the National Institute for Health and Care Excellence (NICE), the body that decides whether treatments should be funded by the NHS, and NHS access remains limited to specialized treatment-resistant depression programs. Private treatment costs run approximately 300 to 600 GBP per infusion session.
Access across the European Union varies by member state. The European Medicines Agency (EMA), the EU regulator responsible for evaluating and approving medicines across member states, has approved esketamine, and Germany offers it along with several private clinics providing IV ketamine, though public system access can involve waiting periods and strict criteria. The Netherlands has a small number of clinics reflecting its generally open approach to mental health treatment innovation. France and Spain offer esketamine mainly through hospital-based psychiatric programs, with off-label IV ketamine clinics uncommon. Scandinavian countries take a cautious regulatory approach, with esketamine available in some hospital settings but few private clinics. Eastern Europe has very limited access, mostly through research settings or a small number of private practitioners.
Australia has emerged as one of the more progressive countries for ketamine therapy outside North America. The Therapeutic Goods Administration (TGA), Australia's regulator for medicines and medical devices, has approved esketamine for treatment-resistant depression, and a growing number of psychiatrists offer IV ketamine in private practice in Sydney, Melbourne, Brisbane, and Perth. Treatment typically requires a psychiatrist referral and costs approximately 500 to 800 AUD per infusion. Private health insurance may cover part of the cost in hospital settings, but Medicare, Australia's public health system, provides limited coverage, so out-of-pocket costs remain significant for most patients.
New Zealand has more limited access than Australia. Ketamine is available for medical use and some psychiatrists prescribe it off-label for treatment-resistant depression, but dedicated ketamine clinics are uncommon. Access tends to run through hospital-based psychiatric services or individual private psychiatrists in Auckland and Wellington, and patients typically need to show that conventional treatments have failed before ketamine therapy is considered.
Mexico has a developing ketamine therapy scene, with private clinics in Mexico City, Guadalajara, and Monterrey offering IV infusions at costs generally lower than the US, often 200 to 400 USD per infusion. Some medical tourism companies arrange ketamine therapy in Mexico for US and Canadian patients seeking lower-cost treatment. If you're considering this route, verify the provider's medical credentials, the clinic's safety protocols, and the quality of the medication being used before booking. Our guide to provider safety protocols covers what to check regardless of where you're being treated.
Brazil has a growing interest in ketamine therapy supported by research programs at several universities, with private clinics in Sao Paulo and Rio de Janeiro offering infusions, though the market is smaller than Mexico's. Elsewhere in Latin America, access is generally limited. Argentina has some clinics, particularly in Buenos Aires, but in most other countries ketamine therapy for mental health is unavailable outside research settings.
India presents a distinct case. Ketamine is widely available as an anesthetic and is relatively inexpensive, and a small but growing number of psychiatrists in Delhi, Mumbai, and Bangalore offer ketamine therapy for depression, often at costs well below Western prices. Clinical infrastructure and oversight are less developed than in the US or Europe, so the quality of care can vary widely.
Japan and South Korea both have strong healthcare systems and active psychiatric research communities, but ketamine therapy for depression is largely still in the research phase. Esketamine has been approved in Japan, with some hospital-based programs offering it for treatment-resistant depression, though private clinics remain uncommon. Access across Southeast Asia and China is very limited. In some countries, ketamine's association with recreational use has led to strict regulatory controls that make medical access harder, and patients interested in ketamine therapy often need to seek treatment abroad.
How to Find a Qualified Provider Internationally
- Start with national or regional psychiatric associations, which can refer you to practitioners offering ketamine therapy.
- Search published medical literature; clinicians who research ketamine therapy in a given country are often among those offering treatment.
- Ask an existing US provider whether they know reputable practitioners in the country you're headed to.
- Verify credentials independently through the relevant national or provincial medical licensing body, and be cautious of clinics that are vague about provider qualifications.
- Contact university-affiliated teaching hospitals, which are often early adopters of newer treatments like ketamine therapy.
Telehealth Has Location Limits
Most US-based telehealth ketamine providers can only prescribe to patients who are physically located in a state where the provider is licensed. If you're an American or Canadian expat, this generally means you need to be in the country where your provider holds a license to receive a prescription, not simply be a citizen of that country.
Some expats coordinate care around trips home, picking up prescriptions and medication during US visits and managing treatment with remote consultations in between. This requires careful planning and cooperation with the prescribing provider. If you live somewhere with its own ketamine therapy infrastructure, establishing local care is usually the more practical long-term approach. Bring your medical records and treatment history to help a new provider understand your background.
These ranges are approximate and vary by clinic, city, and treatment protocol. Confirm current pricing directly with any provider before booking. For a fuller look at what drives cost and how coverage works, see our insurance coverage guide.
If you're weighing treatment abroad, continuity of care deserves as much attention as the treatment itself. Our guide to questions about continuity of care can help you evaluate any provider, international or domestic.
What to Consider Before Seeking Treatment Abroad
- Prioritize quality of care over cost; a cheaper treatment isn't a bargain if the provider lacks training or proper monitoring equipment.
- Plan for continuity of care, since ketamine therapy works best as an ongoing treatment plan rather than a one-time event.
- Confirm the legal status of ketamine in both your home country and your destination before making plans.
- Make sure the provider and clinical team can communicate with you clearly if you don't speak the local language fluently.
- Carry a full medical history, including psychiatric history, current medications, prior ketamine treatment details, and relevant lab work.
- Identify a provider back home who can continue your care before you travel.
Key Takeaway
Ketamine therapy is expanding globally, driven by growing research and clinician awareness, but the pace varies by country. According to the World Health Organization, depression affects more than 280 million people worldwide, and access to newer treatments like ketamine therapy remains uneven even as evidence grows. Countries with strong private healthcare sectors and flexible regulatory frameworks tend to adopt treatments like ketamine therapy faster than those with centralized public systems.
Helpful next step
Before committing to a provider anywhere, know what safety protocols and credentials to verify first.
Learn More
Have questions about starting ketamine therapy or evaluating a provider, wherever you are?
Frequently Asked Questions
Yes, in many countries. Ketamine is a controlled substance almost everywhere, but licensed physicians can prescribe it for medical use in countries including Canada, the UK, Germany, Australia, Mexico, Brazil, and India. Legal status and how easy it is to actually find a provider are two different things, so check both before making plans.
Esketamine has regulatory approval in Canada, the UK, the European Union, Australia, and Japan, among other countries. Availability through public health systems is usually limited, so most patients access it through private clinics or specialized hospital programs.
Generally not. Most US-based telehealth ketamine providers can only prescribe to patients who are physically located in a state where the provider is licensed, so living outside the US typically means the prescription isn't valid. Some expats coordinate treatment around visits home instead.
Verify the provider's medical license and credentials, confirm the clinic has proper monitoring equipment, understand the legal status of ketamine in that country, and plan for continuity of care with a provider back home before you travel.
Share
Related Reading
Need help or want to reach readers?
Have a correction, provider question, or advertising inquiry? Reach the editorial team.